Sign In
Buy BMY
$54.72
+0.260 (+0.477%)
At Close: Jun 03, 2026
American Century Companies Inc. Purchases 97,089 Shares of Bristol Myers Squibb Company $BMY
04:15am, Wednesday, 26'th Nov 2025
American Century Companies Inc. increased its holdings in Bristol Myers Squibb Company (NYSE: BMY) by 4.3% during the second quarter, according to the company in its most recent disclosure with the Se
BMY Wins EC Nod for Label Expansion of CAR T Cell Therapy Breyanzi
03:06pm, Tuesday, 25'th Nov 2025
Bristol Myers wins EC approval to expand Breyanzi's label, adding MCL patients to its growing roster of European CAR-T indications.
Market Today: Alphabet rallies, Amazon's $50B AI push
05:35pm, Monday, 24'th Nov 2025
Guru Stock PicksElfun Trusts has made the following transactions:Reduce in MLM by 7.18%Sold out in KVUEAdd in TXN by 36.84%New position in AMDStock News Tech-le
PRINCETON, N.J.--(BUSINESS WIRE)---- $BMY #Breyanzi--BMS Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma.
Bayer Stroke Drug Hits Trial Goals, Analyst Sees Positive Data Readout From Bristol Myers' Milvexian After Failed Study
01:14pm, Monday, 24'th Nov 2025
Bayer AG (OTC: BAYRY) released topline results from the Phase 3 OCEANIC-STROKE study, with its investigational, once daily, oral FXIa inhibitor asundexian.
Bristol Myers Squibb to Host Hematology-Focused Investor Event
06:59am, Monday, 24'th Nov 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb to Host Hematology-Focused Investor Event.
Bristol-Myers Squibb: I See No Catalysts To Break Underperformance
08:00am, Friday, 21'st Nov 2025
Bristol-Myers Squibb (BMY) faces a severe patent cliff, risking up to 60% of recent revenues as key blockbusters lose exclusivity. BMY's pipeline and recent acquisitions are unlikely to offset revenue
Bristol Myers Squibb (NYSE:BMY) Stock Unloaded Rep. Gilbert Ray Cisneros, Jr.
02:15am, Friday, 21'st Nov 2025
Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Bristol Myers Squibb Company (NYSE: BMY). In a filing disclosed on November 18th, the Representative disclosed that they
Bristol Myers, Sanofi sued by Texas over Plavix
04:06pm, Thursday, 20'th Nov 2025
Texas Attorney General Ken Paxton sued Bristol Myers Squibb and Sanofi , accusing the drugmakers of failing to disclose that Plavix, which is used to prevent blood clots, does not work effectively for
Will Librexia ACS Study Setback Dent BMY's Cardiovascular Portfolio?
02:11pm, Thursday, 20'th Nov 2025
BMY ends its Librexia ACS study after an interim review shows milvexian is unlikely to meet goals, while other late-stage studies continue.
The Tech Rotation Is On and Dividend-Paying Blue-Chips Are the Winners
08:19am, Thursday, 20'th Nov 2025
Technology investors are rotating into dividend stocks as a response to several growing market pressures.
This Drugmaker Is Too Cheap to Ignore. Why Bristol Is a Buy.
08:00am, Thursday, 20'th Nov 2025
Bristol Myers Squibb trades at seven times earnings, with multiple growth drivers.
Investors Heavily Search Bristol Myers Squibb Company (BMY): Here is What You Need to Know
10:01am, Wednesday, 19'th Nov 2025
Zacks.com users have recently been watching Bristol Myers (BMY) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers
02:25pm, Tuesday, 18'th Nov 2025
PRINCETON, N.J.--(BUSINESS WIRE)--Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers.
Why Bristol-Myers Squibb Remains Undervalued In 2025
09:26am, Tuesday, 18'th Nov 2025
Bristol-Myers Squibb remains my favorite, almost the only Big Pharma stock that hasn't left the accumulation zone. Sales of its "gem" in the cardiovascular franchise, Camzyos, were $296 million in Q3,
